{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:17:37Z","timestamp":1776763057657,"version":"3.51.2"},"reference-count":24,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The aim of this study was to examine the prevalence of multidrug-resistant tuberculosis (MDR-TB) within the tuberculosis (TB) population in Huzhou City, identify associated risk factors, furnish reference values for clinical practice, and establish standardized anti-TB treatment regimens. Retrospectively analyzing data from TB patients in Huzhou City encompassed 2,261 cases with sputum smear positive and 1,754 cases with sputum smear negative from January 2016 to December 2022. There were 3.66%(147\/4,015) TB patients identified as MDR-TB. Multivariate logistic regression analysis showed that the risk of developing MDR-TB in individuals with comorbidities was 9.17 times higher than in individuals without comorbidities (odds ratio [OR] = 9.17, 95% confidence interval [CI]: 6.5\u201312.93,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001). The risk of progressing to MDR-TB with a positive sputum smear was 1.93 times higher than with a negative one (OR = 1.93, 95% CI: 1.35\u20132.77,\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001). The risk of developing MDR-TB was 1.69 times higher in patients had smoking history than in those without (OR = 1.69, 95% CI: 1.11\u20132.56,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.014). The main risk factors for developing MDR-TB were male patients, smoking history, sputum smear positive, farmer, body mass index \u226418.5, retreated cases, and those combination of diabetes or pneumoconiosis.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1081","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T01:51:36Z","timestamp":1742608296000},"source":"Crossref","is-referenced-by-count":3,"title":["Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China"],"prefix":"10.1515","volume":"20","author":[{"given":"Haiyan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaowei","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqiu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuchu","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Infection, Huzhou Central Hospital, Huzhou Key Laboratory of Precision Medicine Research and Translation for Infectious Diseases , 1558 Sanhuan North Road, Wuxing District , Huzhou , Zhejiang, 313000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"2025122123391331563_j_biol-2025-1081_ref_001","unstructured":"World Health Organization. Global tubercuosis report. Geneva: World Health Organization; 2022."},{"key":"2025122123391331563_j_biol-2025-1081_ref_002","doi-asserted-by":"crossref","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillug E, Fatimad R, Mwabah P, et al. Global tuberculosis report 2020 \u2013 Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113(Suppl 1):S7\u201312. 10.1016\/j.ijid.2021.02.107.","DOI":"10.1016\/j.ijid.2021.02.107"},{"key":"2025122123391331563_j_biol-2025-1081_ref_003","doi-asserted-by":"crossref","unstructured":"Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS One. 2022;17(6):e0270003. 10.1371\/journal.pone.0270003.","DOI":"10.1371\/journal.pone.0270003"},{"key":"2025122123391331563_j_biol-2025-1081_ref_004","unstructured":"Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment-2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar J-WC, Anderson LF, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018;392(10150):821\u201334. 10.1016\/S0140-6736(18)31644-1."},{"key":"2025122123391331563_j_biol-2025-1081_ref_005","doi-asserted-by":"crossref","unstructured":"Yin QQ, Jiao WW, Li QJ, Xu F, Li JQ, Sun L, et al. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. BMC Microbiol. 2016;16(1):85\u201395. 10.1186\/s12866-016-0699-2.","DOI":"10.1186\/s12866-016-0699-2"},{"key":"2025122123391331563_j_biol-2025-1081_ref_006","doi-asserted-by":"crossref","unstructured":"Luo D, Chen Q, Xiong GC, Peng YP, Liu T, Chen XW, et al. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China. Sci Rep. 2019;9(1):7315\u201322. 10.1038\/s41598-019-43547-2.","DOI":"10.1038\/s41598-019-43547-2"},{"key":"2025122123391331563_j_biol-2025-1081_ref_007","doi-asserted-by":"crossref","unstructured":"Zhao YL, Xu SF, Wang LX, Chin DP, Wang SF, Jiang GL, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161\u201370. 10.1056\/NEJMoa1108789.","DOI":"10.1056\/NEJMoa1108789"},{"key":"2025122123391331563_j_biol-2025-1081_ref_008","doi-asserted-by":"crossref","unstructured":"Wang GR, Wang SQ, Jiang GL, Yang XT, Huang ML, Huo FM, et al. Xpert MTB\/RIF ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study. J Infect. 2019;78(4):311\u20136. 10.1016\/j.jinf.2019.02.010.","DOI":"10.1016\/j.jinf.2019.02.010"},{"key":"2025122123391331563_j_biol-2025-1081_ref_009","doi-asserted-by":"crossref","unstructured":"Song WM, Li YF, Ma XB, Liu JY, Tao NN, Liu Y, et al. Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004\u20132018. Respir Res. 2019;20(1):223\u201335. 10.1186\/s12931-019-1199-3.","DOI":"10.1186\/s12931-019-1199-3"},{"key":"2025122123391331563_j_biol-2025-1081_ref_010","doi-asserted-by":"crossref","unstructured":"Wotale TW, Lelisho ME, Negasa BW, Tareke SA, Gobena WE, Amesa EG. Identifying risk factors for recurrent multidrug resistant tuberculosis based on patient\u2019s record data from 2016 to 2021: retrospective study. Sci Rep. 2024;14:23912. 10.1038\/s41598-024-73209-x.","DOI":"10.1038\/s41598-024-73209-x"},{"key":"2025122123391331563_j_biol-2025-1081_ref_011","doi-asserted-by":"crossref","unstructured":"Fantahun A, Ermias A, Addisalem G, Tagesse S, Taye G. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: A case \u2013 control study. BMJ Open. 2023;13:e061836. 10.1136\/bmjopen-2022-061836.","DOI":"10.1136\/bmjopen-2022-061836"},{"key":"2025122123391331563_j_biol-2025-1081_ref_012","doi-asserted-by":"crossref","unstructured":"Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016;387(10026):1427\u201380. 10.1016\/S0140-6736(16)00619-X.","DOI":"10.1016\/S0140-6736(16)00619-X"},{"key":"2025122123391331563_j_biol-2025-1081_ref_013","doi-asserted-by":"crossref","unstructured":"Wang ZZ, Hou Y, Guo TF, Jiang T, Xu L, Hu HX, et al. Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China. Front Public Health. 2023;11:1117101. 10.3389\/fpubh.2023.1117101.","DOI":"10.3389\/fpubh.2023.1117101"},{"key":"2025122123391331563_j_biol-2025-1081_ref_014","doi-asserted-by":"crossref","unstructured":"Nelson KN, Shah NS, Mathema B, Ismail N, Brust JCM, Brown TS, et al. Spatial patterns of extensively drug-resistant tuberculosis transmission in KwaZulu-Natal, South Africa. J Infect Dis. 2018;218 (1):1964\u201373. 10.1093\/infdis\/jiy394.","DOI":"10.1093\/infdis\/jiy394"},{"key":"2025122123391331563_j_biol-2025-1081_ref_015","doi-asserted-by":"crossref","unstructured":"Ortblad KF, Salomon JA, B\u00e4rnighausen T, Atun R. Stopping tuberculosis: A biosocial model for sustainable development. Lancet. 2015;386(10010):2354\u201362. 10.1016\/S0140-6736(15)00324-4.","DOI":"10.1016\/S0140-6736(15)00324-4"},{"key":"2025122123391331563_j_biol-2025-1081_ref_016","doi-asserted-by":"crossref","unstructured":"Lyu MY, Wang DM, Zhao JW, Yang ZW, Chong W, Zhao ZZ, et al. A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus. Int J Infect Dis. 2020;97:69\u201377. 10.1016\/j.ijid.2020.05.080.","DOI":"10.1016\/j.ijid.2020.05.080"},{"key":"2025122123391331563_j_biol-2025-1081_ref_017","doi-asserted-by":"crossref","unstructured":"Jamshidi P, Danaei B, Arbabi M, Mohammadzadeh B, Khelghati F, Aghababa AA, et al. Silicosis and tuberculosis: A systematic review and meta-analysis. Pulmonology. 2023;5(1):1\u201312. 10.1016\/j.pulmoe.2023.05.001.","DOI":"10.1016\/j.pulmoe.2023.05.001"},{"key":"2025122123391331563_j_biol-2025-1081_ref_018","doi-asserted-by":"crossref","unstructured":"Wu B, Yu Y, Du CT, Liu Y, Hu DY. Epidemiology of drug-resistant tuberculosis in Chongqing, China: A retrospective observational study from 2010 to 2017. PLoS One. 2019;14(12):e0216018. org\/10.1371\/journal.pone.0216018.","DOI":"10.1371\/journal.pone.0216018"},{"key":"2025122123391331563_j_biol-2025-1081_ref_019","doi-asserted-by":"crossref","unstructured":"Song WM, Guo J, Xu TT, Li SJ, Liu JY, Tao NN, et al. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. BMC Pulm Med. 2021;21:399. 10.1186\/s12890-021-01774-2.","DOI":"10.1186\/s12890-021-01774-2"},{"key":"2025122123391331563_j_biol-2025-1081_ref_020","doi-asserted-by":"crossref","unstructured":"K\u00f6dm\u00f6n C, Zucs P, van der Werf MJ. Migration-related tuberculosis: Epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Eurosurveillance. 2016;21(12):30164\u2013264. 10.2807\/1560-7917.ES.2016.21.12.30164.","DOI":"10.2807\/1560-7917.ES.2016.21.12.30164"},{"key":"2025122123391331563_j_biol-2025-1081_ref_021","doi-asserted-by":"crossref","unstructured":"Jia HB, Xu YH, Sun ZG. Analysis on drug-resistance-associated mutations among multidrug-resistant mycobacterium tuberculosis isolates in China. Antibiotics. 2021;10(11):1367. 10.3390\/antibiotics10111367.","DOI":"10.3390\/antibiotics10111367"},{"key":"2025122123391331563_j_biol-2025-1081_ref_022","doi-asserted-by":"crossref","unstructured":"Isakova J, Sovkhozova N, Vinnikov D, Goncharova Z, Talaibekova E, Aldasheva N, et al. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. BMC Microbiol. 2018;18(1):22\u201330. 10.1186\/s12866-018-1168-x.","DOI":"10.1186\/s12866-018-1168-x"},{"key":"2025122123391331563_j_biol-2025-1081_ref_023","doi-asserted-by":"crossref","unstructured":"Liu L, Zhao XJ, Wu XY, Li SJ, Liu B, Rajaofera MJN, et al. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019. BMC Microbiol. 2021;21(1):185\u201396. 10.1186\/s12866-021-02246-7.","DOI":"10.1186\/s12866-021-02246-7"},{"key":"2025122123391331563_j_biol-2025-1081_ref_024","doi-asserted-by":"crossref","unstructured":"Guo SQ, Chongsuvivatwong V, Lei SG. Comparison on major gene mutations related to rifampicin and isoniazid resistance between Beijing and non-Beijing strains of mycobacterium tuberculosis: A systematic review and bayesian meta-analysis. Genes. 2022;13(10):1849. 10.3390\/genes13101849.","DOI":"10.3390\/genes13101849"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1081\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T23:39:46Z","timestamp":1766360386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1081\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2025,8,20]]}},"alternative-id":["10.1515\/biol-2025-1081"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1081","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251081"}}